Literature DB >> 15459123

Unraveling the amyloid associated with human medullary thyroid carcinoma.

Ritu Khurana1, Amit Agarwal, Virendra K Bajpai, Nidhi Verma, Ashok K Sharma, Ram P Gupta, Kunnath P Madhusudan.   

Abstract

Medullary thyroid carcinoma (MTC) is associated with amyloid deposition in the surrounding tissues. MTC-positive tumor thyroid tissues surgically removed from patients were used in our study to extract amyloid. We tested the MTC extracts for the presence of amyloid by measuring fold enhancement of thioflavin T fluorescence. Transmission electron microscopic study and atomic force microscopy of MTC patient extracts revealed typical amyloid fibrils. Matrix-assisted laser desorption ionization-time of flight mass spectrometric analysis demonstrated full-length calcitonin as the constituent of the MTC amyloid from seven patients. Our results unequivocally demonstrated that full-length calcitonin is the sole constituent of amyloid in MTC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459123     DOI: 10.1210/en.2004-0780

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

2.  EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.

Authors:  Luca Giovanella; Giorgio Treglia; Ioannis Iakovou; Jasna Mihailovic; Frederik A Verburg; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-04       Impact factor: 9.236

Review 3.  Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.

Authors:  Samuel A Wells; Furio Pacini; Bruce G Robinson; Massimo Santoro
Journal:  J Clin Endocrinol Metab       Date:  2013-06-06       Impact factor: 5.958

4.  Targeting Amyloids with [18F]AV-45 for Medullary Thyroid Carcinoma Positron Emission Tomography/Computed Tomography Imaging: A Pilot Clinical Study.

Authors:  Chun Li; Pengxin Zhang; Ruirui Nie; Xiaoyan Gong; Jinghui Xie; Zilin Yu; Chengdong Wang; Hua Zhang; Ran Yan; Zhi Lu
Journal:  Mol Pharm       Date:  2022-01-04       Impact factor: 4.939

5.  "Triple-negative" non-secretory medullary thyroid cancer: uncommon pathological findings in a rare disease.

Authors:  José Ignacio Martínez-Montoro; Ana María Gómez-Pérez; Elena Gallego; Jorge García-Alemán; Arantzazu Sebastián-Ochoa; Miguel Damas-Fuentes; Isabel Mancha-Doblas; Francisco J Tinahones
Journal:  Arch Med Sci       Date:  2022-04-20       Impact factor: 3.707

Review 6.  Sporadic and familial medullary thyroid carcinoma: state of the art.

Authors:  Tricia A Moo-Young; Amber L Traugott; Jeffrey F Moley
Journal:  Surg Clin North Am       Date:  2009-10       Impact factor: 2.741

7.  Not All β-Sheets Are the Same: Amyloid Infrared Spectra, Transition Dipole Strengths, and Couplings Investigated by 2D IR Spectroscopy.

Authors:  Justin P Lomont; Joshua S Ostrander; Jia-Jung Ho; Megan K Petti; Martin T Zanni
Journal:  J Phys Chem B       Date:  2017-09-19       Impact factor: 2.991

8.  Analysis of Amyloid in Medullary Thyroid Carcinoma by Mass Spectrometry-Based Proteomic Analysis.

Authors:  Lori A Erickson; Julie A Vrana; Jason Theis; Michael Rivera; Ricardo V Lloyd; Ellen McPhail; Jun Zhang
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

9.  An introduction to managing medullary thyroid cancer.

Authors:  Jan Willem de Groot; Thera P Links; Robert Mw Hofstra; John Tm Plukker
Journal:  Hered Cancer Clin Pract       Date:  2006-07-15       Impact factor: 2.857

10.  Effect of Methionine Sulfoxide on the Synthesis and Purification of Aggregation-Prone Peptides.

Authors:  Vanessa Reusche; Franziska Thomas
Journal:  Chembiochem       Date:  2021-03-05       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.